A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc.

系统性硬化症患者护理的综合框架:全球应对改善系统性硬化症诊断和预防策略实践需求的举措

阅读:5
作者:Saketkoo Lesley Ann, Frech Tracy, Varjú Cecília, Domsic Robyn, Farrell Jessica, Gordon Jessica K, Mihai Carina, Sandorfi Nora, Shapiro Lee, Poole Janet, Volkmann Elizabeth R, Lammi Monika, McAnally Kendra, Alexanderson Helene, Pettersson Henrik, Hant Faye, Kuwana Masataka, Shah Ami A, Smith Vanessa, Hsu Vivien, Kowal-Bielecka Otylia, Assassi Shervin, Cutolo Maurizio, Kayser Cristiane, Shanmugam Victoria K, Vonk Madelon C, Fligelstone Kim, Baldwin Nancy, Connolly Kerri, Ronnow Anneliese, Toth Beata, Suave Maureen, Farrington Sue, Bernstein Elana J, Crofford Leslie J, Czirják László, Jensen Kelly, Hinchclif Monique, Hudson Marie, Lammi Matthew R, Mansour Jennifer, Morgan Nadia D, Mendoza Fabian, Nikpour Mandana, Pauling John, Riemekasten Gabriela, Russell Anne-Marie, Scholand Mary Beth, Seigart Elise, Rodriguez-Reyna Tatiana Sofia, Hummers Laura, Walker Ulrich, Steen Virginia
Systemic sclerosis (SSc), the most lethal of rheumatologic conditions, is the cause of death in >50% of SSc cases, led by pulmonary fibrosis followed by pulmonary hypertension and then scleroderma renal crisis (SRC). Multiple other preventable and treatable SSc-related vascular, cardiac, gastrointestinal, nutritional and musculoskeletal complications can lead to disability and death. Vascular injury with subsequent inflammation transforming to irreversible fibrosis and permanent damage characterizes SSc. Organ involvement is often present early in the disease course of SSc, but requires careful history-taking and vigilance in screening to detect. Inflammation is potentially reversible provided that treatment intensity quells inflammation and other immune mechanisms. In any SSc phenotype, opportunities for early treatment are prone to be under-utilized, especially in slowly progressive phenotypes that, in contrast to severe progressive ILD, indolently accrue irreversible organ damage resulting in later-stage life-limiting complications such as pulmonary hypertension, cardiac involvement, and malnutrition. A single SSc patient visit often requires much more physician and staff time, organization, vigilance, and direct management for multiple organ systems compared to other rheumatic or pulmonary diseases. Efficiency and efficacy of comprehensive SSc care enlists trending of symptoms and bio-data. Financial sustainability of SSc care benefits from understanding insurance reimbursement and health system allocation policies for complex patients. Sharing care between recognised SSc centers and local cardiology/pulmonary/rheumatology/gastroenterology colleagues may prevent complications and poor outcomes, while providing support to local specialists. As scleroderma specialists, we offer a practical framework with tools to facilitate an optimal, comprehensive and sustainable approach to SSc care. Improved health outcomes in SSc relies upon recogntion, management and, to the extent possible, prevention of SSc and treatment-related complications.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。